Tag Archives: Neovascular Age-related Macular Degeneration Treatment Industry

Neovascular Age-Related Macular Degeneration Treatment Industry to Reach USD 4.89 Billion by 2033 at a 5% CAGR

The global neovascular age-related macular degeneration (nAMD) treatment market is poised for steady growth, projected to expand from a valuation of USD 3 billion in 2023 to USD 4.89 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 5% over the forecast period, up from a historical CAGR of 3.5% between …

Continue reading “Neovascular Age-Related Macular Degeneration Treatment Industry to Reach USD 4.89 Billion by 2033 at a 5% CAGR”

Global Neovascular Age-related Macular Degeneration Treatment Industry is projected to attain a 5% CAGR by 2033, as per an FMI report

According to a new market research report published by Future Market insights, the global neovascular age-related macular degeneration treatment industry size is expected to grow at a CAGR of 5% from 2023 to 2033, The global neovascular age-related macular degeneration treatment market is expected to garner a market value of US$ 3 billion in 2023, and reaching a market size …

Continue reading “Global Neovascular Age-related Macular Degeneration Treatment Industry is projected to attain a 5% CAGR by 2033, as per an FMI report”